PTC Therapeutics (PTCT) PT Raised to $43 at Barclays
Tweet
Share
E-mail
Get Alerts PTCT Hot Sheet
Price: $69.97 +0.62%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 33
Join SI Premium – FREE
Barclays raised its price target on PTC Therapeutics (NASDAQ: PTCT) to $43.00 (from $40.00) while maintaining a Equalweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Science Applications (SAIC) PT Raised to $140 at Jefferies
- Petroreconcavo SA (RECV3:BZ) PT Lowered to R$12 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
